Medicare is set to cover certain GLP-1 medications, which are used for weight loss, for a monthly cost of $50. This change is expected to impact millions of Americans and is part of a broader expansion of coverage for weight-loss drugs. The specifics of eligibility and coverage details are available for those affected by the change.